Psychotherapy and pharmacotherapy have been the mainstays for the treatment of depression and anxiety disorders during the last century. However, treatment response has not improved in the last few decades. For instance, only half of all patients respond to mainstay antidepressants. To fulfill the needs of the remaining patients, there is a need to find treatments with better efficacy. The addition of psychotherapy to antidepressant treatment has been proven to be superior to either treatment alone. However, the time costs of psychotherapy limit its use for clinicians and patients. Advancements in neuroscience have contributed to an improved understanding of the pathogenesis of depressive and anxiety disorders. In particular, recent advances in the field of fear conditioning provide valuable insight into the treatment of refractory depressive and anxiety disorders. In this review, we studied the reconsolidation-updating paradigm and the concept of epigenetic modification, which has been shown to permanently attenuate remote fear memory. This has implications for drug-augmented psychotherapy. Future research on more sophisticated psychotherapy techniques will make this treatment modality more favorable to both clinicians and patients.
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The changes of emotional behavior in a free fatty acid receptor 1, GPR40/FFAR1, deficient mice Abstract A free fatty acid receptor 1 (GPR40/FFAR1) is G protein coupled receptors which are activated by PUFA including arachidonic acid or docosahexaenoic acid. Our previous study demonstrated that activation of brain GPR40/FFAR1 exerts an antinociceptive effect mediated by the modulation of descending pain control system, and also produced antidepressant-like effect in forced swim test. Thus, we propose that PUFA-GPR40/FFAR1 signaling in the central nervous system could have a various physiological function. Recently, the decrease of polyunsaturated fatty acids (PUFA) in the brain is closely related to the episode and pathological mechanism of psychiatric diseases associate with emotional disorder such as depression and schizophrenia. However, the detail mechanisms remain unknown. In this study, we investigated whether the deficiency of GPR40/FFAR1 signaling have negative effect against emotional behavior. Emotional behavior in wild and GPR40 deficient (KO) male mice was evaluated at 9-10 weeks of age and by elevated plus maze test (EPM), open field test, social interaction test and sucrose preference test. The EPM revealed that the KO mice show reduced anxietylike behavior. Locomotor activity or social interaction behavior is similar between wild and KO mice. In sucrose preference test, the KO mice showed reduced sucrose preference and intake.
Thus, these results suggest that brain GPR40/FFAR1 is associated with the regulation of anxiety behavior and sucrose intake in male mice. (FABP3, H-FABP) binds to the intracellular loop of dopamine D2L receptor and that FABP3 null mouse reveals dysfunction of dopamine-regulated motor coordination (J Neurosci 2010; 30:3146: J Biol Chem 2014; 289:18957) . We here documented that FABP3 null mouse also exhibits an enhanced anxiety and impaired memory extinction like PTSD. Methods: Wild type mice (C57BL6) and FABP3 null mice underwent fear conditioning once a day with consecutive 5 days and measured the fear acquisition and extinction for 35 days. When mice were administrated with melatonin receptor agonist, the drug was orally administrated once a day. Results: The acquisition of contextual fear memory in FABP3 null was not distinguished from those in wild type mice. However, FABP3 null mice had deficits in extinction of contextual fear memory. For example, in one month after exposure to contextual stimulation, wild type mice significantly reduced the elapsed time until entering the chamber given footshock. The elapsed time remained elevated in FABP3 null mice, suggesting the deficits in the extinction. Likewise, the cFos expression in the amygdala after exposure to conditional contextual stimuli remained elevated in FABP3 mice but declined in the wild type mice at one month later. The administration of melatonin receptor agonist completely improved PTSD-like behaviors in FABP3 null mice. Conclusion: FABP3 null mice are novel model of PTSD, which is rescued by melatonin. These works are supported by Kakenhi 26102704 (K.F.). The authors have no financial conflicts of interest to disclose concerning the presentation.
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Prefrontal dopamine-dependent plasticity mediates relapse in an animal model of anxiety disorders The University of Tokyo, Japan Abstract Anxiety disorders are often treated with cognitive-behavioral interventions such as exposure therapy. Fear conditioning and extinction are used in animal models of anxiety disorders and their treatment. Prevention of relapses is a major challenge in treating anxiety disorders. About 40% of patients in remission experience a relapse. In experimental animals, fear can be reinstated by a week footshock (reminder shock) after successful extinction. However, neural circuit mechanisms responsible for fear reinstatement are poorly understood. To identify brain regions involved in processing fear reinstatement, we mapped the regional expression of the inducible immediate early gene, c-Fos. c-Fos expression was elevated in the infralimbic cortex (IL) and lowered in the medial subdivision of the central nucleus of the amygdala (CeM). Electrophysiology experiments revealed that
